{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:34:54Z","timestamp":1789583694046,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.psychres.2019.01.031","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T18:43:34Z","timestamp":1547232214000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Evidence for perturbed metabolic patterns in bipolar disorder subjects associated with lithium responsiveness"],"prefix":"10.1016","volume":"273","author":[{"given":"Manjunath B","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswath","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananthpadmanabha","family":"Kotambail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PSVN","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapaettu","family":"Satyamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.01.031_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/S0007125000292441","article-title":"Who responds to prophylactic lithium therapy?","volume":"21","author":"Abou-Saleh","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0002","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.pnpbp.2005.03.021","article-title":"Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder","volume":"29","author":"Alda","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0003","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.psyneuen.2012.11.014","article-title":"Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of Type D personality","volume":"38","author":"Altmaier","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2019.01.031_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2018.04.010","article-title":"Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: a proton magnetic resonance spectroscopy study","volume":"235","author":"Atag\u00fcn","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2019.01.031_bib0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cts.12324","article-title":"An untargeted metabolomics analysis of antipsychotic use in bipolar disorder","volume":"8","author":"Burghardt","year":"2015","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.psychres.2019.01.031_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1212444","article-title":"Variant GADL1 and response to lithium therapy in bipolar I disorder","volume":"370","author":"Chen","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2019.01.031_bib0008","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.ejhg.5201549","article-title":"Genetics of affective (mood) disorders","volume":"14","author":"Craddock","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.psychres.2019.01.031_bib0009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.braindev.2017.01.008","article-title":"Hyperprolinemia as a clue in the diagnosis of a patient with psychiatric manifestations","volume":"39","author":"Duarte","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.psychres.2019.01.031_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11306-010-0208-9","article-title":"Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions","volume":"6","author":"Fan","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.psychres.2019.01.031_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1399-5618.2009.00709.x","article-title":"Lithium specificity in bipolar illness: a classic agent for the classic disorder","volume":"11","author":"Gershon","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psychres.2019.01.031_bib0012","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2019.01.031_bib0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-5618.2009.00707.x","article-title":"A critical appraisal of lithium's efficacy and effectiveness: the last 60 years","volume":"11","author":"Grof","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psychres.2019.01.031_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cpt.134","article-title":"Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine","volume":"98","author":"Kaddurah-Daouk","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2019.01.031_bib0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/srep00667","article-title":"Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile","volume":"2","author":"Kaddurah-Daouk","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2019.01.031_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00030","article-title":"Molecular mechanisms of bipolar disorder: progress made and future challenges","volume":"11","author":"Kim","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.psychres.2019.01.031_bib0017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/YPG.0000000000000066","article-title":"GADL1 gene polymorphisms and lithium response in bipolar I disorder: lack of association from an Indian population","volume":"25","author":"Kotambail","year":"2015","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.psychres.2019.01.031_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mp.4002130","article-title":"Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder","volume":"14","author":"Lan","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0019","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neulet.2006.05.001","article-title":"Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder","volume":"403","author":"Michelon","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2019.01.031_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11920-014-0499-z","article-title":"Excess mortality in bipolar disorders","volume":"16","author":"Miller","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2019.01.031_bib0021","doi-asserted-by":"crossref","first-page":"e16957","DOI":"10.1371\/journal.pone.0016957","article-title":"The human serum metabolome","volume":"6","author":"Psychogios","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2019.01.031_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12548","article-title":"Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: a postmortem study","author":"Qi","year":"2018","journal-title":"Brain. Pathol."},{"key":"10.1016\/j.psychres.2019.01.031_bib0023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","article-title":"A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics","volume":"258","author":"Ribeiro","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2019.01.031_bib0024","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1038\/tp.2016.145","article-title":"Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants","volume":"6","author":"Rotroff","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv096","article-title":"Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.031_bib0026","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/mp.2015.165","article-title":"Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder","volume":"21","author":"Song","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00003088-200241090-00002","article-title":"Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?","volume":"41","author":"Sproule","year":"2002","journal-title":"Clin. Pharmacokinet"},{"key":"10.1016\/j.psychres.2019.01.031_bib0028","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1021\/ac901502j","article-title":"Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics","volume":"81","author":"Sussulini","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.psychres.2019.01.031_bib0029","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/YPG.0b013e32835d6fad","article-title":"Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder","volume":"23","author":"Tharoor","year":"2013","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.psychres.2019.01.031_bib0031","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/bph.12494","article-title":"A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks","volume":"171","author":"Villase\u00f1or","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2019.01.031_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0033","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.pnpbp.2006.03.012","article-title":"Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings","volume":"30","author":"Yildiz-Yesiloglu","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0034","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/mp.2015.217","article-title":"Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis","volume":"21","author":"Yoshimi","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.031_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbacli.2016.03.008","article-title":"Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder","volume":"5","author":"Yoshimi","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.psychres.2019.01.031_bib0036","doi-asserted-by":"crossref","unstructured":"Young, L.T., Wang, J.-F., 2007. Applying molecular approaches to understand the etiology and treatment of bipolar disorder. 52, 751\u20132.","DOI":"10.1177\/070674370705201201"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118317657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118317657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T17:42:00Z","timestamp":1576777320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118317657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"alternative-id":["S0165178118317657"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.031","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for perturbed metabolic patterns in bipolar disorder subjects associated with lithium responsiveness","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}